Politics Versus Science in Biomedical Research and Development

Wechsler,Jill;

Politics Versus Science in Biomedical Research and Development

July 2, 2004

By Jill Wechsler

Publication

Article

Pharmaceutical TechnologyPharmaceutical Technology-07-02-2004

Volume 28

Issue 7

Decisions to accelerate the approval of AIDS combination drugs, reject the over-the-counter status for the morning-after pill, and limit support for stem cell research are hot political topics.

External Link - article-103357.pdf

Articles in this issue

3M Drug Delivery Systems

AccuRate

July 2004

Characterization of the Performance of Bin Blenders Part 2 of 3: Free-Flowing Mixtures

Investors Shy Away from Pharmaceutical Chemicals

From CGMPs to the Critical Path: FDA Focuses on Innovation, Quality, and Continuous Improvement–Inside and Out

In the Spotlight-July 2004

The LR Method in Critical Areas: Airflow Patterns and the Design of Aseptic Interventions

A Stability Program for the Distribution of Drug Products

Politics Versus Science in Biomedical Research and Development

Related Content

China’s NMPA Approves Merck KGaA Treatment for Tenosynovial Giant Cell Tumor

Patrick Lavery

June 10th 2025

Article

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with TGCTs that require systemic treatment.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

USP Opens Advanced Technology Lab in Maryland

Susan Haigney

June 4th 2025

Article

The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas

May 28th 2024

Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com

Guidance on Quality Culture Standards

Matt Cushing;Susan J. Schniepp

June 3rd 2025

Article

Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.